Pain-control strategies for blind office endometrial biopsy: a systematic review with inert-controlled meta-analysis
Authors: Yue, Bin; Zhao, Cui; Hao, Xiaogang; Kang, Hanqing; Yue, Xiong; Dai, Zhirong; Zhuang, Mengjie; Ji, Xiujia; Wu, Quansheng; Zhang, Xiaohua
Source journal: BMC women's health (2026-08-18)
DOI: 10.1186/s12905-026-04787-3
Abstract
BACKGROUND: Blind office endometrial biopsy is common, but pain during sampling can limit acceptability. Prior reviews have often combined different procedures, comparators, and pain timepoints. We evaluated randomized evidence for pain-control strategies during blind outpatient or office-based endometrial biopsy or sampling. METHODS: For the primary estimand, we restricted meta-analysis to randomized comparisons against placebo, saline, placebo gel, distilled water, or other inert controls, defined as controls without intended analgesic activity, that reported extractable intra-procedural pain scores on a 0-10 compatible scale. We searched PubMed, CENTRAL, Embase, Web of Science, Scopus, Wanfang, VIP, ClinicalTrials.gov, and WHO ICTRP from inception to 9 May 2026, with update checks of PubMed and ClinicalTrials.gov on 12 June 2026. CNKI, SinoMed/CBM, and ChiCTR were checked supplementally. Random-effects mean differences were pooled. Risk of bias was assessed with RoB 2 and certainty with GRADE. RESULTS: The PRISMA-counted searches identified 2632 records; 619 duplicates were removed and 2013 records were screened. Eight randomized trials involving 944 participants were included in the primary meta-analysis. Pain-control interventions lowered average pain during biopsy compared with inert controls (mean difference, -1.87 points; 95% confidence interval, -2.52 to -1.22; I-squared = 86.7%). REML and Hartung-Knapp sensitivity analyses remained directionally consistent, although the prediction interval crossed no effect. Excluding the single systemic COX-2 inhibitor trial left seven local-anesthetic trials and 864 participants with a similar direction of effect (mean difference, -2.10; 95% confidence interval, -2.71 to -1.48; I-squared = 83.7%). Evidence was driven mainly by local anesthetic trials. Harms were sparsely and inconsistently reported. Certainty was low for pain reduction and very low for safety. CONCLUSIONS: Low-certainty randomized evidence suggests that tested pain-control strategies, mainly local anesthetic interventions, may reduce average intra-procedural pain during blind office endometrial biopsy with inert comparators, but heterogeneity is substantial and the optimal intervention class remains uncertain. These findings support patient-centered discussion of pain-control options but do not establish any specific agent or intervention class as standard care. TRIAL REGISTRATION: Not applicable. This systematic review was not prospectively registered.
Related topics
Related open access articles
- CHALLENGES IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH COLORECTAL CANCER AND COVID-19 COINFECTION - CASE REPORT
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- The use of non-invasive ventilation (NIV) in the treatment of patients with COVID-19
- Application of Nanotechnology in Treatment of COVID-19
- Nano Platforms in Combatting COVID-19: Unveiling Antiviral Strategies and Challenges
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.